Login / Signup

Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer.

Zi-Yao HuangLei WenLiu-Fang YeYu-Ting LuWilliam Pat FongRen-Jing ZhangSi-Xian WuZhi-Gang ChenYan-Yu CaiRui-Hua XuYu-Hong LiZi-Ming DuDe-Sheng Wang
Published in: Therapeutic advances in medical oncology (2024)
variant correlate with a poorer prognosis in CRC patients, providing strategies for Wnt-targeted therapy to improve clinical efficacy.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • stem cells
  • cell proliferation
  • peritoneal dialysis
  • prognostic factors
  • single molecule
  • patient reported outcomes
  • dna damage